Authors:
Waubant, E
Gee, L
Bacchetti, P
Sloan, R
Cotleur, A
Rudick, R
Goodkin, D
Citation: E. Waubant et al., Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS, J NEUROIMM, 112(1-2), 2001, pp. 139-145
Citation: Xm. Xu et R. Sloan, Improved tuning prediction for the microstrip coupled dielectric resonatorusing distributed coupling, IEEE MICR T, 49(3), 2001, pp. 553-555
Authors:
Luks, TL
Goodkin, DE
Nelson, SJ
Majumdar, S
Bacchetti, P
Portnoy, D
Sloan, R
Citation: Tl. Luks et al., A longitudinal study of ventricular volume in early relapsing-remining multiple sclerosis, MULT SCLER, 6(5), 2000, pp. 332-337
Citation: M. Zinieris et R. Sloan, Unloaded Q factors, energy storage, and power dissipation of axially symmetric and asymmetric modes of shielded dielectric resonators, ELECTROMAGN, 20(3), 2000, pp. 187-203
Authors:
Bell, C
Bulik, C
Clayton, P
Crow, S
Davis, DM
DeMaso, DR
Dogin, J
Fairburn, CG
Fink, AH
Fisher, M
Forman, S
Garner, DM
Golden, NH
Hagan, J
Kaplan, AS
Katzman, DK
Katzman, MA
Keddy, D
Kottke, TE
Kreipe, R
Lonegran, E
Motto, JA
Mickley, D
Rubel, JB
Schienholtz, M
Schyve, PM
Sloan, R
Sokol, M
Sparrow, J
Strober, M
Stunkard, A
Suchinsky, RT
Swanson, J
Treasure, J
Westermeyer, J
Wilfley, D
Wonderlich, S
Citation: C. Bell et al., Practice guideline for the treatment of patients with eating disorders (revision), AM J PSYCHI, 157(1), 2000, pp. 1
Citation: M. Zinieris et R. Sloan, Unloaded Q-factor of the fundamental TM-mode of a shielded dielectric resonator on a substrate, MICROW OPT, 22(2), 1999, pp. 91-93
Authors:
Waubant, E
Sloan, R
Andersson, PB
Goodkin, D
Citation: E. Waubant et al., A pilot study of the effect of weekly intramuscular 30 mcg interferon beta-1a (Avonex (TM)) on monthly gadolinium-enhanced brain MRI activity in patients with relapsing multiple sclerosis., REV NEUROL, 155, 1999, pp. S20-S23
Authors:
Waubant, E
Goodkin, DE
Gee, L
Bacchetti, P
Sloan, R
Stewart, T
Andersson, PB
Stabler, G
Miller, K
Citation: E. Waubant et al., Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis, NEUROLOGY, 53(7), 1999, pp. 1397-1401
Authors:
Waubant, E
Sloan, R
Gee, L
Stewart, T
Andersson, PB
Stabler, G
Miller, K
Goodkin, D
Citation: E. Waubant et al., Serum level of matrix metalloprotease-9 (MMP-9) and natural tissue inhibitor of MMP type 1 (TIMP-1) in patients with relapsing-remitting multiple sclerosis (RRMS): Relationship to MRI activity, MULT SCLER, 4(6), 1998, pp. 507-507